Heterogeneity in Tumors and Resistance to EGFR TKI Therapy—Letter

Podobne knjige/članki

• Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench
  od: Suda, Kenichi, et al.
  Izdano: (2016)
• Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation
  od: Suda, Kenichi, et al.
  Izdano: (2016)
• Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell Lines
  od: Suda, Kenichi, et al.
  Izdano: (2017)
• Inter-tumor heterogeneity of PD-L1 status: is it important in clinical decision making?
  od: Suda, Kenichi, et al.
  Izdano: (2020)
• Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
  od: Suda, Kenichi, et al.
  Izdano: (2021)